Apr 8, 2022 Syros Presents New Preclinical Data on its CDK12 Inhibitor Program at American Association for Cancer Research (AACR) Annual Meeting 2022
Mar 15, 2022 Syros Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
Mar 9, 2022 Syros to Report Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 15, 2022
Mar 8, 2022 Syros to Present New Preclinical Data on its CDK12 Inhibitor Program at the American Association for Cancer Research (AACR) Annual Meeting 2022
Jan 10, 2022 Syros Announces Clinical Updates and 2022 Goals to Support its Advancement to a Fully Integrated Biopharmaceutical Company
